The effect of liver disease on inhibitory and plasma protein-binding displacement interactions: an update

Author： Palatini Pietro Orlando Rocco De Martin Sara

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.6, Iss.10, 2010-10, pp. : 1215-1230

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Retinol-Binding Protein 4 and New Adipocytokines in Nonalcoholic Fatty Liver Disease

Current Pharmaceutical Design, Vol. 16, Iss. 17, 2010-06 ,pp. : 1921-1928

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of Liver Disease on Pharmacokinetics: An Update

By Rodighiero V.

Clinical Pharmacokinetics, Vol. 37, Iss. 5, 1999-11 ,pp. : 399-431

Adis International

Access to resources Recommend Favorite

Plasma / Serum Protein Binding Determinations

Current Drug Metabolism, Vol. 9, Iss. 9, 2008-11 ,pp. : 854-859

Bentham Science Publishers

Access to resources Recommend Favorite

Towards Accurate Free Energy Calculations in Ligand Protein-Binding Studies

Current Medicinal Chemistry, Vol. 17, Iss. 8, 2010-03 ,pp. : 767-785

Bentham Science Publishers

Access to resources Recommend Favorite

The Effect of Albumin-genotype on Ibuprofen Displacement of Nifedipine from its Binding Sites

Current Pharmaceutical Analysis, Vol. 11, Iss. 1, 2015-02 ,pp. : 53-59

Bentham Science Publishers

Access to resources Recommend Favorite